A Phase 1 Single Dose Escalation Study of Palifermin Administered Pre-Transplant Conditioning in Subjects Undergoing Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

被引：1
|
作者：
Ostojic, Alen
Holtzman, Noa G.
Curtis, Lauren M.
Shaffer, Brian C.
Rubin, Jeffrey S.
Hakim, Frances T.
Mays, Jacqueline W.
Heller, Theo
Cowen, Edward W.
Werner, Sabine
Emanuel, Michael
Steinberg, Seth M.
Gress, Ronald E.
Pavletic, Steven Z.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] EFFECT OF PRE-TRANSPLANT BODY MASS INDEX IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Dang, Brian N.
    De Oliveira, Satiro
    Gray, Ashley
    Wilhalme, Holly
    Bowles, LaVette S.
    Chang, James
    Moore, Theodore B.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S227 - S227
  • [22] Pilot Study - Composite Risk Score for Pre-Transplant Risk Assessment in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
    Kaur, Jaskiran
    Altman, Rebekah
    Muthukutty, Anusha
    Ragupathi, Madhu
    Pineiro, Luis
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [23] A Phase I Dose Escalation Study of Lenalidomide Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
    Andritsos, Leslie A.
    Blum, William
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Penza, Sam
    Lee, Jodi
    Marcucci, Guido
    Byrd, John C.
    Devine, Steven M.
    BLOOD, 2014, 124 (21)
  • [24] Allogeneic and matched unrelated donor hematopoietic stem cell transplantation (HSCT) for hematologic malignancies using a modified reduced intensity conditioning regimen.
    Raflores, M
    Rossetti, J
    Lister, J
    Shadduck, R
    Lech, J
    Kaplan, R
    Kennedy, M
    Schunn, G
    BLOOD, 2005, 106 (11) : 416B - 416B
  • [25] Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy In Adults with Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation
    Giermasz, Adam
    Damon, Lloyd E.
    Kaplan, Lawrence D.
    Navarro, Willis H.
    Hege, Kristen
    Linker, Charles
    Martin, Thomas
    BLOOD, 2010, 116 (21) : 564 - 564
  • [26] The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Wilhelm, Kaci
    Chemaly, Roy
    Saliba, Rima
    Gulbis, Alison
    Saunders, Ila
    Cool, Rita
    Ferguson, Jill
    Westmoreland, Michael
    Rondon, Gabriela
    Kebriaei, Partow
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (04) : 257 - 262
  • [27] Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation
    Ehrlich, K. B.
    Miller, G. E.
    Scheide, T.
    Baveja, S.
    Weiland, R.
    Galvin, J.
    Mehta, J.
    Penedo, F. J.
    BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1594 - 1598
  • [28] Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis Treated With Ruxolitinib in The Pre-Transplant Period
    Mensah-Glanowska, Patrycja
    Szeremet, Agnieszka
    Nasilowska-Adamska, Barbara
    Majcherek, Maciej
    Jakubas, Beata
    Halaburda, Kazimierz
    Wrobel, Tomasz
    Czyz, Anna
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 146 - 147
  • [29] Clinical Impact of Pre-transplant Pulmonary Impairment on Survival After Allogeneic Hematopoietic Stem Cell Transplantation
    Kakihana, Kazuhiko
    Ohashi, Kazuteru
    Hirashima, Yuka
    Murata, Yutaka
    Kobayashi, Takeshi
    Yamashita, Takuya
    Sakamaki, Hisashi
    Akiyama, Hideki
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (01) : 11 - 16
  • [30] Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation
    K B Ehrlich
    G E Miller
    T Scheide
    S Baveja
    R Weiland
    J Galvin
    J Mehta
    F J Penedo
    Bone Marrow Transplantation, 2016, 51 : 1594 - 1598
12345